PROMAC – Mid-term evaluation of the project – Jamaica

The Government of Jamaica was allocated Euro 22 million by the European Union to support Jamaica’s attainment of Millennium Development Goals “Reduce Child Mortality” and “Improve Maternal Health”. The EU Financing Agreement to effect the implementation of a Programme for Reduction of Maternal and Child Mortality (PROMAC) was signed in 2013. Specific PROMAC objectives included reducing the incidence of neonatal and maternal deaths, improving the quality of management of high-risk pregnancies at both tertiary and primary care levels and enhancing public awareness and understanding of healthcare processes and patients’ rights.

The main objectives of this Evaluation were to provide an overall independent assessment of the past performance of the PROMAC, using the five standard DAC evaluation criteria, namely: relevance, effectiveness, efficiency, sustainability and early signs of impact and to determine to which extent it achieved the expected objectives and to give recommendations based on lessons learned, and the reasons underpinning such results, to improve current and future Actions.

In addition, the evaluation assessed two EU specific evaluation criteria: a) the EU added value and b) the coherence of the Action itself, with the EU strategy in Jamaica and with other EU policies and Member State Actions, and other donors intervening in the health sector.

Duration: September 2019 - September 2020

This project was financed by the EU and the main implementing partners were ANCE and EMERCON.


partner partner partner partner partner partner